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ABSTRACT 
The purpose of the study was to evaluate the single dose oral toxicity of the ethanolic extract from inflorescence of Casuarina equisetifolia, 
Family: Casuarinaceae in female Wistar Rats. The acute toxicity study was carried out based on Organization for Economic Co-operation and 
Development (OECD) Test Guideline 423. However, this plant safety evaluation data was not available so, selected the starting dose from 300 
mg/kg body weight. The animals were orally administered a single dose of 300 mg/kg body weight and followed by 2000 mg/kg body 
weight in next step. Signs of toxicity and mortality were observed after 30 min, 1, 2, 4 and 24h of administration of the extract and once daily 
for 14 days. There was no mortality in the tested animals and no abnormal clinical signs were observed related to test item. No 
abnormalities were detected in gross pathology observations in all the rats at both the dose levels. Based on observations of the present 
study, it can be concluded that the LD50 of ethanolic extract from inflorescence of Casuarina equisetifolia is greater than 2000mg/kg body 
weight and can be classified as Category 5; however, further studies are needed to confirm long term toxicities. 
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INTRODUCTION 
Plants have been extensively used as medicines since a 
thousand years ago and the use of herbal products should 
be based on scientific origin in order to make sure the 
plants are safe to consume1. However, the most commonly 
used herbal formulae have no indications of quality, safety 
and efficacy2. Unfortunately, many people underestimate 
the toxicity of natural products and use them without 
further scientifically testing. Plants or drugs must be 
proven to be safe before they could be used as medicines. 
A key stage in ensuring the safety of drugs is to conduct 
toxicity tests in appropriate animal models, and acute 
toxicity studies are just one of a battery of toxicity tests 
that are used3. 
As per the OECD test guidelines, in order to establish the 
safety of a new drug, toxicological studies are very 
essential in animals like mice, rat, guinea pig, dog, rabbit, 
etc., under various conditions of drug. Regulatory 
authorities do not allow the use of drug clinically without 
its clinical trial which is proceeded by toxicity studies4. 
Acute oral toxicity refers to those adverse effects 
occurring following oral administration of a single dose of 
a substance, or multiple doses given within 24 hours5. 
Objective of the study was to identify a dose causing 
major adverse effects and an estimation of the minimum 
dose causing lethality, according to the regulatory 
guidelines6.  
Casuarina equisetifolia belongs to the family 
Casuarinaceae is found in the dry hill sides and open 
forests of India, Sri Lanka and Australia. The phenolic 
compounds from the needles (branchlets) and bark 
showed significant antioxidant activity. Bark is having 
activities like astringent, in stomacheache, diarrhea, 
dysentery and nervous disorders. Seeds are anthelmintic, 
antispasmodic and antidiabetic. Extracts of leaves exhibit 
anticancer properties. The needles in decoction form used 
as lotion for swelling and also used in the treatment of 
cough and ulcers. The extracts of the fruits, stem and 
leaves are reported to have anti microbial activity. The 
extracts of the areal parts and stem is reported to have 
angiotensin-converting enzyme inhibition activity7. 
The present study has been undertaken to estimate the 
toxic effects of ethanolic extracts from inflorescence of 
Casuarina equisetifolia in female Wistar Rats at the dosage 
of 300, 2000 mg/kg body weight of an animal for a period 
of 14 days using OECD 423, observation and results were 
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recorded accordingly and were reported here to present 
publicly. 
MATERIALS AND METHODS  
MATERIALS  
Collection and preparation of ethanolic extract from 
inflorescence of Casuarina equisetifolia 
The dried inflorescence was collected in bulk from 
Padmabhushan Dr. B.V. Raju foundation, Vishnupur, 
Bhimavaram, West Godavari (District), A.P., India. Then 
the debris and leaves were removed from the collected 
material and dried in shade. The pollen grains were 
separated from inflorescence.  It was coarsely grounded in 
a mixer. The powder was extracted by continuous hot 
extraction using the Soxhlet apparatus at a temperature of 
78ºC for 48 h using 95% ethanol and then evaporating to 
dryness under shade (chloroform was used as a 
preservative while drying). The extract was collected and 
preserved in a desiccator for further studies. 
The plant material was identified and authenticated on 
18/01/2013 by Taxonomist, Prof. Dr. K. Madhava chetty, 
S.V. University, Tirupathi, India, Voucher reference 
number is 2983. 
Animals 
The female (nulliparous and non-pregnant) Wistar rats 
weighing between 164.41 – 191.30 g of 8-12 weeks old 
were used for this study. The animals were procured from 
Sanzyme Limited, Hyderabad, India. The animals were 
acclimatized for 7 days prior to start an experiment in 
polypropylene cages with paddy husk as bedding. Animals 
were housed at a temperature of 23 ± 2°C and relative 
humidity of 50±20%.  A 12:12 light: day cycle was 
followed. The animals were fed with standard pellet feed 
and the food was withdrawn 15-18 h before the 
experiment, although water was allowed ad libitum. The 
animals used for the experiment were approved by 
Institutional animal ethics committee (IAEC) of the 
Anurag Pharmacy College, Kodad, Nalgonda D.t, 
Telangana, India. 
Identification of Animals 
After acclimatization, tail marking was done by using non-
toxic ink for animals and arranged the cage label 
contained the following details: Type of study, extract 
Name, Animal strain, Dose, Step details, Sex, Animal No. 
Body Weight Difference 
During the time of dosing, Body weight difference of the 
animals was not exceeded± 20% of mean weight of each 
set of animals (previously dosed animals). 
Mode of administration  
The extract was administered in a single dose by gavage 
using specially designed  oral needle for rat. 
Justification for Route of Administration 
Oral route was chosen, as it is one of the recommended 
routes of exposure to humans.  
Test substance administration volume  
The administration volume was 10 mL/kg body weight of 
the animal. Based on the body weight of the animal on the 
day of treatment, the quantity of the ethanolic extract of 
Casuarina equisetifolia was calculated. 
METHOD 
As per OECD Guideline 423, two types of acute oral 
toxicity tests i.e. limit test and main test. The limit test is 
primarily used in situations where the experimenter has 
information indicating that the test material is likely to be 
nontoxic, i.e., having toxicity below regulatory limit 
doses6. However, in those situations where there is little 
or no information about its toxicity, or in which the test 
material is expected to be toxic, only the main test should 
be performed, in this experiment the safety related 
literature was not available so, main study was performed 
with the starting dose of 300 mg/kg body weight with 
three animals (see OECD Test Guideline Annex 2c6 – 
Figure 1).  
Experimental Design, Extract Formulation 
Preparation and Dosing:  
Prior to oral administration of ethanolic extract from 
inflorescence of Casuarina equisetifolia (for Step I & Step II 
- 300 mg/kg body weight and for Step III & Step IV - 2000 
mg/kg body weight), the animals were fasted overnight 
for 15-18 h and up to 3-4 h post dosing (see Table: 1).
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Figure 1: OECD Test Guideline Annex 2c6 
 
Table: 1 Experimental Design 
Step 
 
Dose of ethanolic extract from inflorescence 






Step I 300 3 Female 1-3 
Step II 
(Confirmatory) 
300 3 Female 4-6 
Step III 2000 3 Female 7-9 
Step IV 
(Confirmatory) 
2000 3 Female 10-12 
 
Dose Formulation Preparation 
The required amount of ethanolic extract (300 mg and 
2000 mg) was weighed and transferred in mortar. The 
extract was triturated with 1% CMC and then the 
suspension was completely transferred to a 10 mL 
volumetric flask. The 10 mL formulation was prepared 
freshly before oral administration. A dose volume of 10 
mL/kg body weight was maintained in the study period. 
Dose Administration 
The formulated extract was orally administered to animals 
at the respective steps (Step I & Step II - 300 mg/kg body 
weight and for Step III & Step IV - 2000 mg/kg body 
weight) by oral gavage needle in a single dose using 
disposable syringes. 
Observations 
Body weights were taken for all the animals, recorded on 
the first day of dosing and thereafter once every week and 
at the time of termination. Clinical signs were observed for 
each animal at regular intervals (at 30 minutes, 1, 2, and 4 
h) on the day of dosing and once daily for 14 days. 
Observations included changes in skin and fur, eyes and 
mucous membranes and behavioral pattern. Attention was 
given for observations of tremors, convulsions, salivation, 
diarrhea, lethargy, sleep, coma and mortality were 
observed daily up to 14 days. On day 15, all the survived 
animals were terminally sacrificed by the carbon dioxide 
asphyxiation for Gross pathological examination (external 
and internal) for safety assessment. 
RESULTS AND DISCUSSION 
General Clinical Observations, Mortality & Mortality 
No Mortalities were observed in all the animals 
administered with ethanolic extracts from inflorescence of 
Casuarina equisetifolia at 300 and 2000 mg/kg b. wt. and 
no treatment related clinical signs were observed in all the 
Steps (Step I, Step II, Step III and Step IV), (see Table 2). 
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Table 2: Observation for the Test at 300 (Step I & Step II) & at 2000 (Step III & Step IV) mg/kg Body Weight 
Observation for the Test at 300 (Step I & Step II) & at 2000 
 (Step III & Step IV) mg/kg Body Weight 
Observations 30 min. 1 h 2 h 4 h 24 h 48 h 1 week 2 week 
Skin and Fur N N N N N N N N 
Eyes N N N N N N N N 
Mucous Membrane N N N N N N N N 
Salivation N N N N N N N N 
Lethargy Nil Nil Nil Nil Nil Nil Nil Nil 
Sleep N N N N N N N N 
Coma Nil Nil Nil Nil Nil Nil Nil Nil 
Convulsions Nil Nil Nil Nil Nil Nil Nil Nil 
Tremors Nil Nil Nil Nil Nil Nil Nil Nil 
Diarrhea Nil Nil Nil Nil Nil Nil Nil Nil 
Morbidity Nil Nil Nil Nil Nil Nil Nil Nil 
Mortality Nil Nil Nil Nil Nil Nil Nil Nil 
N - Normal 
Body Weights  
All the animals were exhibited a progressive increase in body weight for (Step I & Step II, Step III and Step IV) throughout the 
study period, (see Table 3).  
Table 3:  Mean Body Weights of Step1 to Step IV 
Step/Dose 
 (mg/kg b.wt.) (Animal 
Number) 
Day  
(Mean + SD) 
1 8 14 
Step I/300 
(1, 2 & 3) 
 
171.66 + 4.057 178.46 + 3.804 186.35 + 3.771 
Step II/300 
(4, 5 & 6) 
181.10 + 2.350 188.94 + 3.141 198.99 + 3.171 
Step III/2000 
(7, 8 & 9) 
169.63 + 5.215 178.39 + 8.106 188.55 + 9.393 
Step IV/ 2000 
(10, 11 & 12) 
187.56 + 3.561 199.53 + 6.065 208.62 + 5.706 
 
Gross Pathology  
After completion of study all the animals were terminally 
sacrificed by the carbon dioxide (CO2) asphyxiation. Gross 
pathological examination was performed for all the animals 
(Step I, Step II, Step III and Step IV).  
External Findings/Internal Examination 
No Abnormality Detected (NAD) in external observations 
and internal organs at both dose levels (Step I & Step II - 
300 mg/kg body weight and for Step III & Step IV - 2000 
mg/kg body weight). 
CONCLUSION 
Based on the above observations in this acute oral toxicity 
study of ethanolic extract of from inflorescence of Casuarina 
equisetifolia in Wistar rats, it can be concluded that the 
LD50cut-off value is greater than 2000mg/kg body weight 
and as per Globally Harmonized System for the classification 
of chemicals (GHS), can be classified as Category 5. 
However, further studies are needed to confirm long term 
toxicities.  
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